rs775216604
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_001018113.3(FANCB):c.510T>G(p.Ile170Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000447 in 1,209,182 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 18 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I170L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001018113.3 missense
Scores
Clinical Significance
Conservation
Publications
- Fanconi anemia complementation group BInheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, ClinGen, Labcorp Genetics (formerly Invitae)
- VACTERL association, X-linked, with or without hydrocephalusInheritance: XL Classification: STRONG Submitted by: Genomics England PanelApp
- Fanconi anemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- VACTERL with hydrocephalusInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -7 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| FANCB | NM_001018113.3 | c.510T>G | p.Ile170Met | missense_variant | Exon 3 of 10 | ENST00000650831.1 | NP_001018123.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| FANCB | ENST00000650831.1 | c.510T>G | p.Ile170Met | missense_variant | Exon 3 of 10 | NM_001018113.3 | ENSP00000498215.1 |
Frequencies
GnomAD3 genomes AF: 0.0000269 AC: 3AN: 111442Hom.: 0 Cov.: 24 show subpopulations
GnomAD2 exomes AF: 0.0000437 AC: 8AN: 183104 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000465 AC: 51AN: 1097740Hom.: 0 Cov.: 31 AF XY: 0.0000468 AC XY: 17AN XY: 363142 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000269 AC: 3AN: 111442Hom.: 0 Cov.: 24 AF XY: 0.0000297 AC XY: 1AN XY: 33628 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
This sequence change does not appear to have been previously described in patients with FANCB-related disorders and has been described in the gnomAD database with a low population frequency of 0.0097% in the non-Finnish European subpopulation (dbSNP rs775216604). The p.Ile170Met change affects a moderately conserved amino acid residue located in a domain of the FANCB protein that is not known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Ile170Met substitution. Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Ile170Met change remains unknown at this time. -
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Fanconi anemia Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at